pioglitazone has been researched along with Respiratory Distress Syndrome in 2 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Respiratory Distress Syndrome: A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We examined the effects of pioglitazone, a synthetic ligand of PPAR-gamma, against lung ischemia-reperfusion injury in rats." | 7.72 | Protective effects of preischemic treatment with pioglitazone, a peroxisome proliferator-activated receptor-gamma ligand, on lung ischemia-reperfusion injury in rats. ( Ito, K; Kato, D; Kitamura, N; Naito, Y; Shimada, J; Takagi, T; Toda, S; Yoshikawa, T, 2004) |
| " We examined the effects of pioglitazone, a synthetic ligand of PPAR-gamma, against lung ischemia-reperfusion injury in rats." | 3.72 | Protective effects of preischemic treatment with pioglitazone, a peroxisome proliferator-activated receptor-gamma ligand, on lung ischemia-reperfusion injury in rats. ( Ito, K; Kato, D; Kitamura, N; Naito, Y; Shimada, J; Takagi, T; Toda, S; Yoshikawa, T, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stancioiu, F | 1 |
| Papadakis, GZ | 1 |
| Kteniadakis, S | 1 |
| Izotov, BN | 1 |
| Coleman, MD | 1 |
| Spandidos, DA | 1 |
| Tsatsakis, A | 1 |
| Ito, K | 1 |
| Shimada, J | 1 |
| Kato, D | 1 |
| Toda, S | 1 |
| Takagi, T | 1 |
| Naito, Y | 1 |
| Yoshikawa, T | 1 |
| Kitamura, N | 1 |
1 review available for pioglitazone and Respiratory Distress Syndrome
| Article | Year |
|---|---|
A dissection of SARS‑CoV2 with clinical implications (Review).
Topics: Amiodarone; Animals; COVID-19; Curcumin; Humans; Pioglitazone; Respiratory Distress Syndrome; SARS-C | 2020 |
1 other study available for pioglitazone and Respiratory Distress Syndrome
| Article | Year |
|---|---|
Protective effects of preischemic treatment with pioglitazone, a peroxisome proliferator-activated receptor-gamma ligand, on lung ischemia-reperfusion injury in rats.
Topics: Animals; Capillary Permeability; Cytokines; Ligands; Lipid Peroxidation; Lung; Male; Microcirculatio | 2004 |